Tirzepatide's safety profile in clinical trials extending beyond one year supports the absence of problematic accumulation, with adverse events remaining consistent rather than increasing in frequency or severity over time
In clinical trials, diarrhea is a common side effect, occurring in approximately 30% of patients taking Wegovy (semaglutide 2.4 mg) and 19-23% of patients taking Zepbound (tirzepatide), according to FDA prescribing information
Third, GLP1s influence on gut microbiota and the gutbrain axis may also play a role, given the emerging evidence tying gut health to mental health
Improve insulin function: GLP-1 increases glucose-dependent insulin release and decreases glucagon secretion, helping stabilize blood sugar [13]
These compounds represent an emerging frontier in egg enrichment strategies, with the potential to act synergistically with lipid-soluble antioxidants such as vitamin E and carotenoids
They just cant eat as much as they used to, Jones said